Latest Leadership News

Dexus has reported a strong half-year result with a $348.5 million profit turnaround, robust leasing growth, and strategic capital moves including a $950 million equity raise and a 10% on-market buyback.

INOVIQ Limited reported a $3.96 million net loss for H1 2026, driven by increased R&D spend, while securing $10.2 million to accelerate its exosome-based cancer diagnostics and therapeutics pipeline.

Tivan Limited has initiated comprehensive geophysical surveys across its Molyhil Tungsten and Sandover Fluorite Projects, aiming to refine exploration targets and guide drilling in 2026. The program includes advanced airborne and ground surveys designed to reveal new mineralisation beneath cover.

Celsius Resources has appointed Peter Hume as interim chairman while progressing the sale of its Opuwo project and reclaiming a key 60% shareholding in its Philippine affiliate after funding obligations were unmet.

Spark New Zealand’s H1 FY26 results reveal a strong rebound in profitability driven by mobile service revenue growth and disciplined cost reductions, alongside the strategic sale of its data centre business.

BCAL Diagnostics reported a slight revenue decline and a persistent net loss in its half-year results, with auditors flagging concerns over its ability to continue without additional funding.

Carnavale Resources has retracted and replaced its recent investor presentation to correct overstated financial forecasts for gold prices above AUD 6,500/oz, reaffirming robust economics for its Kookynie Gold Project.

Stavely Minerals has locked in a $500,000 unsecured director loan facility to fund its 2026 Scoping Study targeting copper, gold, and silver production. This non-dilutive funding move underscores confidence from within the board as the company advances key projects.

Cauldron Energy has announced a major uranium resource upgrade at its Yanrey Project in Western Australia, now exceeding 55 million pounds of uranium oxide. Backed by strong project economics and fully funded drilling for 2026, the company is poised to capitalise on the global nuclear resurgence amid ongoing policy challenges.

Alligator Energy has completed commissioning of its Samphire pilot plant and is set to begin a four-month uranium field recovery trial, signalling a key step towards project development.

Nexalis Therapeutics has completed a key capital raising milestone, issuing new shares, options, and performance rights following shareholder approval. This move supports the company’s clinical-stage drug development programs targeting pain and mental health.

Resolution Minerals has reported final assay results from its 2025 drilling campaign at the Golden Gate prospects in Idaho, revealing extensive near-surface gold mineralisation alongside significant tungsten intercepts. The findings confirm the potential for a large, open-ended gold-tungsten deposit, setting the stage for accelerated exploration in 2026.